Prospective evaluation of some candidate tumor markers in the diagnosis of pancreatic cancer

Digestive Diseases and Sciences
C R MackieA H Rubenstein

Abstract

As part of a prospective diagnostic protocol, patients suspected of having pancreatic cancer had systemic and portal venous blood samples assayed, in coded batches, for peptide hormones and enzymes thought to be of potential value as tumor markers. An average of 111 patients were tested for each candidate marker. Results were analyzed by dividing patients into three groups according to the definitive diagnoses. These were pancreatic cancer (32% of patients), other cancers (27%), and benign diseases (41%). Although elevated mean levels of fasting plasma glucose and serum alkaline phosphatase were found in the pancreatic cancer group, there were no significant differences in the mean levels of any of the candidate markers studied in the three groups. The diagnostic values of normal and elevated levels of each candidate marker studied have been calculated. None has proven to be as useful as the serum level of pancreatic oncofetal antigen, fasting plasma glucose, or serum alkaline phosphatase in the diagnosis or exclusion of pancreatic cancer.

References

Nov 1, 1978·The Journal of Surgical Research·A R MoossaA W Hall
May 1, 1975·The Journal of Clinical Investigation·G W SizemoreJ M Larson
Oct 1, 1976·Current Problems in Cancer·S R Friesen
Jul 1, 1977·Clinical Endocrinology·R L HimsworthL H Rees
Sep 15, 1977·The New England Journal of Medicine·W D Odell
Jan 19, 1978·The New England Journal of Medicine·A A MihasR G Gibson
Sep 1, 1977·Current Problems in Cancer·J M Howard, G L Jordan
Dec 1, 1978·The American Journal of Digestive Diseases·S S SchwartsA H Rubenstein
Mar 1, 1978·Cancer·P J FitzgeraldM H Poleski
Jan 1, 1975·Annals of Internal Medicine
Jan 1, 1976·Clinical Endocrinology·C J HillyardI MacIntyre
Aug 1, 1976·The Journal of Surgical Research·R A WoodD B Skinner
Jul 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·K K Reddi, J F Holland
Sep 4, 1975·The New England Journal of Medicine·A E Cocco, S J Conway
Sep 1, 1975·British Journal of Cancer·M EllisonA M Neville
Jan 1, 1976·The Journal of Clinical Endocrinology and Metabolism·S F KukuA H Rubenstein
Apr 15, 1972·Lancet·J R HayesK D Buchanan
Mar 16, 1974·Lancet·G MilhaudM S Moukhtar
Aug 1, 1973·Metabolism: Clinical and Experimental·B D Weintraub, S W Rosen
May 1, 1969·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·A G Pearse
Jun 23, 1966·The New England Journal of Medicine·M H McGavranM E Levin
Sep 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·F MelaniD F Steiner
May 16, 1974·The New England Journal of Medicine·O L SilvaR H Snider
Jul 1, 1974·Clinical Endocrinology·L H Rees, J G Ratcliffe
Jul 15, 1972·American Journal of Obstetrics and Gynecology·J L VaitukaitisG T Ross
Jul 26, 1973·The New England Journal of Medicine·D PowellJ T Potts
Jun 30, 1973·British Medical Journal·J P RooneyF O'Connor
Jan 1, 1973·Annals of Internal Medicine·G D BraunsteinG T Ross
Mar 29, 1973·The New England Journal of Medicine·G W SizemoreC D Arnaud
Dec 1, 1973·The Journal of Clinical Investigation·B D Weintraub, S W Rosen
Jul 1, 1970·American Journal of Orthodontics·R P Hotz
Feb 12, 1970·The New England Journal of Medicine·J E McGuigan, W L Trudeau
Jan 1, 1971·The Journal of Clinical Investigation·C D ArnaudT Littledike
May 22, 1969·Biochemical and Biophysical Research Communications·J L ClarkD F Steiner
May 26, 1966·The New England Journal of Medicine·T J Vecchio
Jan 1, 1967·The Journal of Clinical Endocrinology and Metabolism·L M SherwoodJ T Potts
Mar 1, 1963·The Medical Clinics of North America·R MURPHY, F H SMITH

❮ Previous
Next ❯

Citations

Sep 1, 1983·Digestive Diseases and Sciences·T T WhiteH Miyashita
Jan 1, 1982·Digestive Diseases and Sciences·H Z KupchikV L Go
Sep 6, 1984·The New England Journal of Medicine·A R Moossa
May 1, 1993·Psychosomatics·A I Green, C P Austin
Aug 1, 1981·Current Problems in Cancer·E D HolyokeM S Arnott
Dec 1, 1984·Psychological Reports·P M Coons, V Milstein
Dec 1, 1989·The British Journal of Surgery·P A ClavienA R Moossa
May 7, 2005·Evolution & Development·Armin P Moczek, Lisa M Nagy
Nov 17, 2006·Nature Reviews. Cancer·Lauren M F MerloCarlo C Maley
Jan 1, 1983·Cancer Metastasis Reviews·G H Heppner, B E Miller
May 20, 2000·Annals of the New York Academy of Sciences·L TheodorS Bar-Meir
Dec 1, 1990·Baillière's Clinical Gastroenterology·J M Rhodes, C K Ching

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Japanese Journal of Surgery
M ImamuraT Tobe
The Australian Journal of Experimental Biology and Medical Science
B A Herriott, A A PALMER
The American Journal of Digestive Diseases
G A GRESHAM
Clinica Chimica Acta; International Journal of Clinical Chemistry
K Lorentz
Biochemical and Biophysical Research Communications
B J Allan, T T White
© 2021 Meta ULC. All rights reserved